Alba Ramos-Llorca is a PhD researcher at the Medicinal Chemistry Group of the University of Antwerp, Belgium (UAMC). Her PhD project is part of the Integrated Training in Dry Eye Disease Drug Development (IT-DED3) consortium funded by the EU Horizon 2020 Research and Innovation programme, Marie Skłodowska-Curie Action. She obtained a Double Master’s Degree in Medicinal Chemistry and Drug Discovery and Safety at the University of Copenhagen, Denmark, and the Vrije Universiteit Amsterdam, the Netherlands, in 2018. Her research focuses on the synthesis and biochemical evaluation of new activity-based probes and inhibitors targeting serine proteases. This research can potentially lead to new biomarkers and target discovery for pathologies where serine proteases play a pivotal role.
University of Antwerp
Antwerp, Flanders, Belgium